INJEX Pharma AG
INJEX Pharma AG, headquartered in Germany, is a pioneering company in the pharmaceutical and medical device industry, specialising in innovative drug delivery systems. Founded in 2006, INJEX has made significant strides in developing needle-free injection technology, which enhances patient comfort and compliance. The company’s flagship product, the INJEX 30, offers a unique solution for administering medications without needles, making it particularly appealing in the fields of diabetes management and vaccinations. With a strong presence in Europe and expanding operations globally, INJEX Pharma AG is recognised for its commitment to quality and innovation, positioning itself as a leader in the needle-free injection market. Notable achievements include various partnerships and collaborations aimed at advancing healthcare solutions, solidifying its reputation as a forward-thinking entity in the pharmaceutical landscape.
DitchCarbon Score
How does INJEX Pharma AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Land Transportation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
INJEX Pharma AG's score of 10 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
INJEX Pharma AG's reported carbon emissions
INJEX Pharma AG, headquartered in Germany, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific commitments or initiatives from INJEX Pharma AG, it is challenging to assess their current stance on climate change and emissions reduction.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
INJEX Pharma AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
